Beta Program for New Caristix Application
July 14, 2011
We’re now accepting beta users for a new software application that will simplify the scoping of HL7 integration projects. Who’s Eligible Hospital IT team members
We’re now accepting beta users for a new software application that will simplify the scoping of HL7 integration projects. Who’s Eligible Hospital IT team members
Stéphane Vigot, Caristix co-founder and president, is presenting today at the International Startup Festival, a new conference on the business of startups. He’ll be pitching
We’ve just released Test v1.18, Caristix software for testing HL7 interfaces. This release includes two new features. Database Connection Library Caristix Test now includes a
This week’s roundup covers enterprise data modeling, a possible slowdown in the Meaningful Use timeline, a new HIE software release, and interoperability. Enterprise Data Modeling:
This week, we have a couple of HIE news items out of the US Midwest, a new Canadian iPad/ICU implementation, and a warning not to
We’re starting a new feature on the Caristix blog: a quick weekly roundup of noteworthy news, articles, and comments on healthcare integration and healthcare IT.
HL7 Interfacing Advice from the Indiana Health Information Exchange The largest health information exchange (HIE) in the US is located in Indiana. It connects 80
Information Week ran an article this week on protecting patient data. The article wasn’t on one of the usual suspects — a HIPAA violation or
Jean-Luc Morin, VP R&D at Caristix, has a guest post on Shahid Shah’s blog, Healthcare IT Guy. Shahid’s top-ranked blog covers healthcare IT, EMR, EHR,
A few weeks ago, I was working on an HL7 v3 project with an outside partner and the discussion turned to market adoption. We came
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.